Influence of anti-arrhythmic drugs on potassium and sodium content of the rat myocardium.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D004077:Digoxin / Q000494:pharmacology; D006325:Heart Atria / Q000032:analysis; D006352:Heart Ventricles / Q000032:analysis; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008297:Male; D009206:Myocardium / Q000032:analysis*; D010672:Phenytoin / Q000494:pharmacology; D010946:Plants, Medicinal; D011188:Potassium / Q000032:analysis*; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011926:Rauwolfia / Q000494:pharmacology; D012964:Sodium / Q000032:analysis*
D000889:Anti-Arrhythmia Agents; D010672:Phenytoin; D004077:Digoxin; D012964:Sodium; D011433:Propranolol; D011342:Procainamide; D011188:Potassium